BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26

• Press Releases

  Teva Study Finds Only 23% of Younger Adults with Mood Disorders and Tardive Dyskinesia (TD) Symptoms Are Formally Diagnosed with TD Despite Widespread Impact

  May 18, 2026

   · 

  7 min read
• Press Releases

  Daré Bioscience Initiates Phase 2 Study of DARE-HPV, a Novel Pharmacologic Treatment for Persistent High-Risk HPV Infection with No FDA-Approved Therapies

  May 18, 2026

   · 

  13 min read
• Press Releases

  BioVie Announces Completion of Phase 2 SUNRISE-PD Trial in Early-Stage Parkinson’s Disease

  May 18, 2026

   · 

  8 min read
• Press Releases

  Kyverna Therapeutics Names Greg Martini as Chief Financial Officer

  May 18, 2026

   · 

  6 min read
• Press Releases

  EmStop™ Announces Initiation of CAPTURE-2 IDE Clinical Trial

  May 18, 2026

   · 

  2 min read
• Press Releases

  U.S. FDA Accepts Viatris New Drug Application for Fast-Acting Meloxicam for the Treatment of Moderate-to-Severe Acute Pain

  May 18, 2026

   · 

  9 min read
• Press Releases

  Astellas to Present Data on Long-Term Outcomes and Clinical Use of Its Portfolio Across Disease Stages at ASCO 2026

  May 18, 2026

   · 

  36 min read
• Press Releases

  MS Pharma Announces Strategic Growth Investment from Olayan Financing Company

  May 18, 2026

   · 

  4 min read
• Press Releases

  Quince Announces Acquisition of Orphai and up to $187 Million Private Placement to Advance Pulmonary Pipeline

  May 18, 2026

   · 

  14 min read
• Press Releases

  Quince Therapeutics Announces Clinically Meaningful Improvements Across Functional, Hemodynamic and Biomarker Measures in Phase 2 Study in PAH and PH-ILD

  May 18, 2026

   · 

  10 min read